Skip to Content

ICI-based treatment as first-line therapy improves outcomes in patients with nccRCC

Recent real-world data to support the use of ICI-based or VEGF-TKI treatment as first-line therapy in patients with nccRCC.

Get access to the article

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top